<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Primary effusion <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (PEL) is a common <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e> patients closely associated with <z:hpo ids='HP_0100726'>Kaposi's sarcoma</z:hpo>-associated herpesvirus (KSHV) </plain></SENT>
<SENT sid="1" pm="."><plain>Previously, we showed that KSHV latency associated nuclear antigen (LANA) stabilizes intracellular activated Notch1 (ICN) involved in maintenance of the malignant phenotype of KSHV infected PEL cells in vitro </plain></SENT>
<SENT sid="2" pm="."><plain>The gamma-secretase inhibitor (GSI) which specifically blocks the production of ICN slows down the proliferation of the KSHV infected PEL cell lines BCBL1, BC3 as well as JSC1 in vitro </plain></SENT>
<SENT sid="3" pm="."><plain>In this study, we extended these studies to explore the possibility that manipulation of the Notch signaling by GSI would prevent the growth of the PEL <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> in vivo </plain></SENT>
<SENT sid="4" pm="."><plain>We observed that the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:mp ids='MP_0002006'>tumorigenesis</z:mp> of KSHV infected PELs was significantly delayed in GSI treated <z:mp ids='MP_0002536'>SCID</z:mp> mice harboring the PEL cell lines </plain></SENT>
<SENT sid="5" pm="."><plain>We also found that GSI treatment resulted in <z:mp ids='MP_0001651'>necrosis</z:mp> as well as <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> generated by the xenotransplanted KSHV positive PEL cell lines </plain></SENT>
<SENT sid="6" pm="."><plain>In contrast, GSI had no effect on mice harboring BJAB cells, a KSHV negative Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cell line where ICN levels were negligible </plain></SENT>
<SENT sid="7" pm="."><plain>Our study provides further evidence to suggest that targeted downregulation of abnormal Notch signaling has therapeutic potential for KSHV related primary effusion <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
</text></document>